Drug profile · INN
trifluridine + tipiracil
LONSURF 15/6.14
trifluridine + tipiracil (LONSURF 15/6.14) is an FDA-listed pharmaceutical active ingredient. Associated with Servier Laboratories (Aust.) Pty..
TGA: approved
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — trifluridine + tipiracil
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 0
- Data quality
- 0.81
Quick answer
trifluridine + tipiracil (LONSURF 15/6.14) is an FDA-listed pharmaceutical active ingredient. Associated with Servier Laboratories (Aust.) Pty..
Key facts
Approval history
| Authority | Status | Date |
|---|---|---|
| TGA | approved | — |
Frequently asked questions
What is trifluridine + tipiracil?
trifluridine + tipiracil (LONSURF 15/6.14) is an FDA-listed pharmaceutical active ingredient. Associated with Servier Laboratories (Aust.) Pty..
What is the brand name for trifluridine + tipiracil?
LONSURF 15/6.14 is a marketed brand name for trifluridine + tipiracil. Check FDA Drugs@FDA for the current US label holder and prescribing information.